388 results on '"Nanayakkara, Shane"'
Search Results
2. Incidence, Predictors, and Outcomes of Nonhome Discharge Following Transcatheter Aortic Valve Implantation: A Multicenter Australian Experience—The NHD TAVI Study
3. Artificial neural networks for ECG interpretation in acute coronary syndrome: A scoping review
4. Predictors of pacemaker requirement in patients receiving implantable loop recorders for unexplained syncope: A systematic review and meta-analysis
5. The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction
6. Acute Kidney Injury Following Transcatheter Aortic Valve Implantation—A Contemporary Perspective of Incidence, Predictors, and Outcomes
7. Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF
8. Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
9. Early Discharge to Clinic-Based Therapy of Patients Presenting With Decompensated Heart Failure (EDICT-HF): Study Protocol for a Multi-Centre Randomised Controlled Trial
10. Coronary Artery Disease Risk Prediction in Patients With Severe Aortic Stenosis: Development and Validation of the Aortic Stenosis-Coronary Artery Disease (AS-CAD) Score
11. Moving towards understanding the "hole" story in HFpEF
12. Prevalence and outcomes of patients with SMuRF-less acute coronary syndrome undergoing percutaneous coronary intervention
13. Post-Procedure Monocyte Count Levels Predict Major Adverse Cardiovascular Events (MACE) Following Transcatheter Aortic Valve Implantation (TAVI) for Aortic Stenosis
14. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial
15. Long-Term Valve Durability in Patients Undergoing Transcatheter Aortic Valve Implantation
16. Ten‐Year Risk Equations for Incident Heart Failure in Established Atherosclerotic Cardiovascular Disease Populations
17. Characterization of Cardiac Sympathetic Nervous System and Inflammatory Activation in HFpEF Patients
18. Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis.
19. Multimorbidity and multiple causes of death in heart failure
20. Short- and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Public and Private Hospital Settings: A Propensity-Matched Analysis
21. A Structured Multidisciplinary Education Program for Improving Cardiovascular Risk and Glycaemic Control in Patients with Type 2 Diabetes Mellitus
22. Long-Term Outcomes Stratified by Body Mass Index in Patients Undergoing Transcatheter Aortic Valve Implantation
23. Impact of Gender on Transcatheter Aortic Valve Implantation Outcomes
24. Device Based Approaches to the Prevention of Contrast-Induced Acute Kidney Injury
25. Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: Time to close the gender gap
26. Association Between Urine Output and Mortality in Critically Ill Patients: A Machine Learning Approach
27. Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: a systematic review and Bayesian meta-analysis
28. Influence of Impaired Conduction on Exercise Hemodynamics in Patients With Preserved Ejection Fraction
29. A Digital Application to Assist With Device Selection in Patients Who Undergo Transcatheter Aortic Valve Implantation
30. Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention
31. Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions
32. Resting and Exercise Doppler Hemodynamics: How and Why?
33. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis
34. Extended Release Oral Milrinone, CRD-102, for Advanced Heart Failure
35. Differences in predictors of incident heart failure according to atherosclerotic cardiovascular disease status.
36. No Longer From Pillar to Post: The First Effective Step in Treating Heart Failure with Preserved Ejection Fraction
37. Identifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS‐AF Score
38. Influence of Impaired Conduction on Exercise Hemodynamics in Patients With Preserved Ejection Fraction
39. Mechanisms of the Improvement in Peak VO2 With Exercise Training in Heart Failure With Reduced or Preserved Ejection Fraction
40. Haemodynamic and metabolic adaptations in coronary microvascular disease
41. Left atrial enlargement is associated with pulmonary vascular disease in heart failure with preserved ejection fraction
42. New-onset atrial fibrillation prediction: the HARMS2-AF risk score.
43. Impact of Concomitant Mitral Regurgitation on the Hemodynamic Indicators of Aortic Stenosis
44. Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
45. Management of Heart Failure With Preserved Ejection Fraction: A Review
46. Long-Term Valve Durability in Patients Undergoing Transcatheter Aortic Valve Implantation
47. Editorial: Translating artificial intelligence into clinical use within cardiology
48. Physiologic Insights Into Long COVID Breathlessness
49. Avoiding the re-do sternotomy: treatment of an ascending aortic pseudoaneurysm using a percutaneous Amplatzer PFO closure device.
50. Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid‐range and preserved ejection fraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.